Before taking Kazano, tell your healthcare provider about any medical conditions, allergies, or medications you are taking.
Kazano is a prescription medication used to improve blood sugar control in adults with type 2 diabetes mellitus. It combines two active ingredients that work together to lower elevated blood sugar levels.
Alogliptin belongs to a class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors. It helps increase insulin release when blood sugar levels are high and reduces excess glucose production after meals.
Metformin belongs to a class of medications called biguanides. It reduces glucose production in the liver and helps the body’s cells respond more effectively to insulin.
Although Kazano can help manage type 2 diabetes, it may cause serious side effects in people with certain medical conditions, particularly kidney disease, liver problems, or heart failure.
Your healthcare provider will assess your medical history, kidney function, blood sugar levels, and other medications before recommending treatment.
Lactic Acidosis
Kazano may rarely cause lactic acidosis, a serious and potentially life-threatening condition in which too much lactic acid builds up in the bloodstream.
Lactic acid is a substance produced naturally when the body uses glucose for energy.
Normally, the liver and kidneys help maintain healthy levels of lactic acid.
However, certain medical conditions or medications can interfere with this process, allowing lactic acid to accumulate.
The metformin component of Kazano is associated with a rare risk of lactic acidosis, particularly when the body cannot eliminate the medication properly.
The risk may increase in people with kidney impairment, significant liver disease, severe dehydration, or conditions that reduce oxygen delivery to body tissues.
Possible symptoms include:
- Severe Weakness: Feeling unusually tired or lacking energy.
- Muscle Pain: Unexplained muscle aches or discomfort.
- Difficulty Breathing: Rapid, deep, or labored breathing.
- Abdominal Pain: Persistent stomach discomfort, sometimes accompanied by nausea or vomiting.
- Unusual Drowsiness: Feeling extremely sleepy or less alert than normal.
- Dizziness: Feeling faint or lightheaded.
- Slow or Irregular Heartbeat: Changes in heart rhythm that may occur in severe cases.
- Feeling Unusually Cold: A decrease in body temperature.
Lactic acidosis may develop gradually, and its early symptoms can resemble those of other illnesses.
Stop taking Kazano and seek emergency medical attention immediately if you develop symptoms suggesting lactic acidosis.
Lactic acidosis requires urgent hospital treatment and should not be managed at home.
Your healthcare provider may recommend temporarily stopping Kazano during serious illness, severe dehydration, or other situations that increase the risk of lactic acidosis.
Kidney Disease and Renal Impairment
Kazano should not be used by people with certain levels of kidney impairment.
The kidneys play an important role in removing both alogliptin and metformin from the body.
Metformin is eliminated largely unchanged through the kidneys.
When kidney function decreases, metformin may accumulate in the bloodstream, increasing the risk of lactic acidosis.
Alogliptin also requires dosage adjustments in people with reduced kidney function.
Because Kazano combines both medications in fixed doses, it may not provide the flexibility needed for patients with kidney disease.
Kidney function is commonly measured using a test called the estimated glomerular filtration rate (eGFR).
According to current U.S. prescribing information, Kazano is not recommended when eGFR is below 60 mL/min/1.73 m², because patients with reduced kidney function may require a lower alogliptin dose than the combination tablet provides.
The medication is contraindicated in patients with severe kidney impairment, defined as an eGFR below 30 mL/min/1.73 m².
Your healthcare provider will check your kidney function before starting Kazano and periodically during treatment.
People with kidney disease may experience symptoms such as:
- Swelling: Fluid buildup in the ankles, feet, or hands.
- Changes in Urination: Urinating less frequently or noticing changes in urine output.
- Fatigue: Persistent tiredness or weakness.
- Nausea: Ongoing stomach discomfort.
- Loss of Appetite: Reduced interest in eating.
However, kidney disease may develop without noticeable symptoms, making regular blood tests especially important.
Tell your healthcare provider if you have chronic kidney disease, reduced kidney function, or a history of kidney problems.
Your healthcare provider may recommend another diabetes medication if Kazano is not appropriate for your kidney function.
Low Blood Sugar (Hypoglycemia)
Kazano may increase the risk of hypoglycemia, particularly when taken with insulin or certain other diabetes medications.
Hypoglycemia occurs when blood sugar falls below the level needed for normal body function.
Alogliptin helps stimulate insulin release in response to elevated blood sugar, while metformin reduces glucose production in the liver.
When Kazano is taken alone, the risk of hypoglycemia is generally low.
However, combining Kazano with insulin or sulfonylureas, such as glimepiride or gliclazide, may increase the risk.
Possible symptoms include:
- Shakiness: Trembling or feeling unsteady.
- Sweating: Sudden sweating without physical activity.
- Increased Hunger: Feeling unusually hungry.
- Dizziness: Lightheadedness or difficulty maintaining balance.
- Rapid Heartbeat: A racing or pounding heartbeat.
- Headache: Pain or pressure in the head.
- Confusion: Difficulty concentrating or thinking clearly.
- Weakness: Sudden tiredness or reduced energy.
Severe hypoglycemia may cause seizures, loss of consciousness, or an inability to swallow safely.
If your blood sugar falls below 70 mg/dL (3.9 mmol/L), follow your healthcare provider’s instructions for treating low blood sugar.
For most conscious adults who can swallow safely, treatment involves consuming 15 grams of fast-acting carbohydrates, waiting 15 minutes, and checking blood sugar again.
If blood sugar remains low, repeat the treatment as directed.
Seek emergency medical attention if someone becomes unconscious, experiences a seizure, or cannot swallow safely.
Your healthcare provider may adjust your insulin or sulfonylurea dosage when starting Kazano to reduce the risk of hypoglycemia.
Vitamin B12 Deficiency
Long-term use of metformin, one of the active ingredients in Kazano, may reduce vitamin B12 levels.
Vitamin B12 is an essential nutrient that helps maintain healthy red blood cells, supports nerve function, and contributes to normal DNA production.
Metformin may interfere with vitamin B12 absorption in the digestive system.
Over time, reduced vitamin B12 absorption can lead to a deficiency.
A significant deficiency may cause anemia or neurological symptoms.
Possible signs include:
- Fatigue: Persistent tiredness or reduced energy.
- Weakness: Difficulty performing normal activities.
- Pale Skin: An unusually pale appearance.
- Tingling or Numbness: Unusual sensations in the hands or feet.
- Balance Problems: Difficulty walking steadily.
- Memory or Concentration Problems: Trouble remembering information or focusing.
- Sore Tongue: Pain, redness, or inflammation of the tongue.
Some symptoms of vitamin B12 deficiency may resemble diabetic neuropathy, a complication of diabetes that affects the nerves.
Tell your healthcare provider if you experience new numbness, tingling, or persistent fatigue while taking Kazano.
Your healthcare provider may recommend periodic vitamin B12 testing, especially if you develop anemia or nerve-related symptoms.
Vitamin B12 deficiency can often be treated with appropriate supplementation when identified.
Do not start high-dose supplements without discussing your needs with your healthcare provider.
Heart Failure and Cardiovascular Conditions
Kazano should be used with caution in people who have heart failure or are at increased risk of developing it.
Heart failure occurs when the heart cannot pump blood effectively enough to meet the body’s needs.
The alogliptin component of Kazano has been associated with concerns about heart failure in certain patients.
Clinical trials involving alogliptin have reported heart failure events, making it important to consider individual cardiovascular risk before starting treatment.
Metformin may also increase the risk of lactic acidosis in people experiencing acute heart failure or other serious conditions that reduce oxygen delivery to body tissues.
Possible symptoms of heart failure include:
- Shortness of Breath: Difficulty breathing during physical activity or while resting.
- Swelling: Fluid buildup in the feet, ankles, or legs.
- Rapid Weight Gain: Sudden weight increases caused by fluid retention.
- Persistent Fatigue: Unusual weakness or tiredness.
- Difficulty Breathing While Lying Down: Needing additional pillows to breathe comfortably.
- Reduced Exercise Tolerance: Becoming tired or breathless during normal activities.
Tell your healthcare provider if you have a history of heart failure, coronary artery disease, or other significant cardiovascular conditions.
Your healthcare provider will consider the benefits and risks of Kazano and may recommend closer monitoring or an alternative diabetes treatment.
Contact your healthcare provider promptly if you notice new swelling, rapid weight gain, or worsening breathing difficulties.
Seek emergency medical attention if you experience severe shortness of breath, chest pain, or fainting.
Allergic Reactions and Hypersensitivity
Do not take Kazano if you have experienced a serious allergic reaction to alogliptin, metformin, or any other ingredient in the medication.
Some people may develop allergic reactions, including serious skin reactions or swelling beneath the skin.
Alogliptin has been associated with rare but serious hypersensitivity reactions, including anaphylaxis, angioedema, and Stevens-Johnson syndrome.
Possible symptoms include:
- Skin Rash: Red or irritated areas of skin.
- Itching: Persistent skin irritation.
- Hives: Raised, itchy bumps.
- Facial Swelling: Swelling around the eyes, lips, or face.
- Throat Tightness: Difficulty swallowing or breathing.
- Skin Blisters: Painful blisters or peeling skin that may indicate a serious skin reaction.
- Mouth Sores: Painful sores involving the mouth or other mucous membranes.
Severe allergic reactions can develop suddenly and require immediate medical attention.
Stop taking Kazano and contact your healthcare provider if you develop signs of an allergic reaction.
Seek emergency medical attention immediately if you experience difficulty breathing, swelling of the tongue or throat, or a widespread blistering skin rash.
Do not restart Kazano after a serious allergic reaction unless your healthcare provider specifically determines that it is safe.
Liver Disease and Hepatic Impairment
Kazano is not recommended for people with significant liver impairment.
The liver helps regulate blood sugar levels and plays an important role in processing lactate.
Although metformin is mainly eliminated through the kidneys rather than being extensively metabolized by the liver, liver disease can interfere with the body’s ability to clear lactate.
This may increase the risk of lactic acidosis.
The alogliptin component has also been associated with reports of serious liver injury, including rare cases of liver failure.
Possible symptoms of liver problems include:
- Jaundice: Yellowing of the skin or whites of the eyes.
- Dark Urine: Urine that appears unusually dark.
- Upper Abdominal Pain: Discomfort on the upper-right side of the abdomen.
- Nausea: Persistent stomach upset.
- Loss of Appetite: Reduced desire to eat.
- Unusual Fatigue: Ongoing tiredness or weakness.
- Pale Stools: Bowel movements that appear lighter than normal.
Tell your healthcare provider if you have hepatitis, cirrhosis, or a history of abnormal liver function tests.
Your healthcare provider may recommend checking liver function before treatment or when symptoms suggest liver injury.
Stop taking Kazano and seek prompt medical advice if you develop symptoms suggesting serious liver damage.
Your healthcare provider will determine whether another diabetes medication is more appropriate.
Surgery and Medical Procedures Using Contrast Dye
Tell your healthcare provider if you are scheduled for surgery or a medical imaging procedure while taking Kazano.
Certain procedures may temporarily affect kidney function, hydration, or blood circulation.
These changes can increase the risk of complications involving the metformin component of Kazano.
Surgery
Patients undergoing major surgery may need to temporarily stop Kazano.
Surgery can sometimes involve fasting, changes in fluid intake, dehydration, or temporary changes in blood pressure.
These factors may increase the risk of lactic acidosis in susceptible individuals.
Your healthcare provider will explain when to stop taking Kazano and when it is safe to restart treatment.
Do not discontinue Kazano before a minor procedure unless instructed.
Imaging Procedures Using Iodinated Contrast
Some imaging procedures, including certain CT scans and angiograms, use iodinated contrast dye to make internal structures easier to see.
In some patients, iodinated contrast can cause an acute decline in kidney function.
Reduced kidney function may lead to metformin accumulation and increase the risk of lactic acidosis.
Kazano may need to be stopped at or before contrast administration, depending on your kidney function, medical history, and the type of procedure.
For patients who require interruption, kidney function is generally reassessed approximately 48 hours after the procedure before Kazano is restarted.
Not every imaging procedure requires Kazano to be stopped. Your healthcare provider will determine whether temporary interruption is necessary.
Always inform the healthcare team performing your procedure that you take Kazano.
Pregnancy and Breastfeeding
Tell your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding before taking Kazano.
Blood sugar control is especially important during pregnancy because uncontrolled diabetes can increase the risk of complications for both the pregnant person and the developing baby.
However, the safety of the alogliptin and metformin combination during pregnancy has not been adequately established.
There is limited information about the effects of alogliptin during human pregnancy.
Metformin has been studied more extensively, and available research has not shown a clear increase in major birth defects. However, this does not establish the safety of the fixed combination product.
Your healthcare provider may recommend a different diabetes treatment during pregnancy, depending on your condition and blood sugar levels.
Breastfeeding
It is not known whether alogliptin passes into human breast milk.
Metformin passes into breast milk in small amounts, but information about the combined effects of alogliptin and metformin on breastfed infants is limited.
Your healthcare provider will consider your need for diabetes treatment, the benefits of breastfeeding, and any potential risks to your baby.
Do not start or continue Kazano during pregnancy or breastfeeding without medical advice.
If you become pregnant while taking Kazano, contact your healthcare provider promptly to review your treatment plan.
Use in Older Adults
Older adults may be more sensitive to certain side effects of Kazano, particularly those associated with reduced kidney function.
Kidney function often decreases with age, which can affect how efficiently metformin and alogliptin are eliminated from the body.
When kidney function is significantly reduced, metformin may accumulate and increase the risk of lactic acidosis.
Older adults may also have additional medical conditions, including heart disease, liver problems, or dehydration, that affect treatment safety.
Your healthcare provider may recommend:
- Kidney Function Monitoring: More frequent blood tests to assess kidney health.
- Blood Sugar Monitoring: Regular glucose testing to evaluate treatment effectiveness.
- Medication Reviews: Checking for interactions with other prescription medications.
- Hydration Monitoring: Ensuring adequate fluid intake when appropriate.
- Dosage Assessment: Reviewing whether the prescribed dosage remains suitable.
Tell your healthcare provider if you experience persistent weakness, dizziness, dehydration, or unusual changes in your blood sugar readings.
Do not adjust your Kazano dosage without medical advice.
Other Important Precautions
Kazano may also cause other serious side effects that require medical attention.
Pancreatitis
Alogliptin has been associated with acute pancreatitis, an inflammation of the pancreas.
Symptoms may include severe, persistent abdominal pain that sometimes spreads to the back, with or without vomiting.
Stop taking Kazano and seek immediate medical evaluation if you develop symptoms suggesting pancreatitis.
Severe Joint Pain
DPP-4 inhibitors, including alogliptin, have been associated with severe and sometimes disabling joint pain.
Tell your healthcare provider if you develop significant joint pain after starting Kazano.
Bullous Pemphigoid
Bullous pemphigoid is a rare skin condition that causes large, fluid-filled blisters.
Cases have been reported in patients taking DPP-4 inhibitors.
Contact your healthcare provider promptly if you develop unexplained skin blisters or sores.
When to Contact Your Healthcare Provider
Contact your healthcare provider if you experience persistent nausea, unusual fatigue, frequent low blood sugar readings, swelling, worsening digestive symptoms, or changes in your urination.
Tell your healthcare provider if you develop kidney problems, liver disease, or heart failure, or if you are scheduled for surgery or a contrast imaging procedure.
Seek prompt medical attention if you experience persistent abdominal pain, unexplained skin blisters, or symptoms suggesting liver injury.
Seek emergency medical attention if you develop severe breathing difficulties, unusual drowsiness with profound weakness, loss of consciousness, or symptoms suggesting lactic acidosis.
Kazano can help manage type 2 diabetes, but safe treatment requires regular monitoring of kidney function, blood sugar levels, and possible side effects. Following your prescribed dosage, attending medical appointments, and reporting unusual symptoms can help reduce the risk of serious complications.
REVIEWS